BioMarin Pharmaceutical | Dochód Netto



Net Income Zmiana Data
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
Agios Pharmaceuticals USD -96523000 1.04B 2024-12
Alnylam Pharmaceuticals USD -83763000 27.81M 2024-12
Amgen USD 627M 2.2B 2024-12
Bayer EUR -335000000 3.85B 2024-12
Biogen USD 266.7M 121.8M 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
Incyte USD 201.21M 94.76M 2024-12
Insmed USD -235548000 15.02M 2024-12
Ionis Pharmaceuticals USD -104349000 36.13M 2024-12
Moderna USD -1120000000 1.13B 2024-12
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
PTC Therapeutics USD -65886000 40.77M 2024-12
Regeneron Pharmaceuticals USD 917.7M 422.9M 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 2.82B 1.7B 2024-09
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
Ultragenyx Pharmaceutical USD -133385000 131K 2024-12
United Therapeutics USD 301.3M 7.8M 2024-12
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



BioMarin Pharmaceutical Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.